Saturday, July 25, 2020

Pharma Reviews: Cipla Set to Launch Repurposed Drug Favipiravir for COVID-19 Patients in India: CSIR

It is an Active Pharmaceutical Ingredient (API), meaning it is biologically active. CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has developed ...
Read more: Cipla Set to Launch Repurposed Drug Favipiravir for COVID-19 Patients in India: CSIR